Litigation Details for Takeda Pharmaceuticals U.S.A., Inc. v. Sun Pharmaceutical Industries Ltd. (D. Del. 2022)
✉ Email this page to a colleague
Takeda Pharmaceuticals U.S.A., Inc. v. Sun Pharmaceutical Industries Ltd. (D. Del. 2022)
Docket | ⤷ Try for Free | Date Filed | 2022-07-07 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | None | Referred To | |
Patents | 8,846,100; 9,173,857 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Takeda Pharmaceuticals U.S.A., Inc. v. Sun Pharmaceutical Industries Ltd.
Details for Takeda Pharmaceuticals U.S.A., Inc. v. Sun Pharmaceutical Industries Ltd. (D. Del. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2022-07-07 | External link to document | |||
2022-07-07 | 3 | ANDA Form | Expiration of Patent: U.S. Patent No. 8,846,100 expires on August 24, 2029 and U.S. Patent No. 9,173,857… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) … 7 July 2022 1:22-cv-00911 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2022-07-07 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,846,100 B2; 9,173,857 B2. (… 7 July 2022 1:22-cv-00911 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |